By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


InSite Vision, Inc. 

965 Atlantic Avenue

Alameda  California  94501  U.S.A.
Phone: 510-865-8800 Fax: 510-865-5700



Company News
InSite Vision (ISV) Reports Third Quarter 2014 Financial Results 11/6/2014 10:50:40 AM
InSite Vision (ISV) To Report Third Quarter 2014 Financial Results On November 5, 2014 10/29/2014 9:12:43 AM
InSite Vision (ISV) Reports Second Quarter 2014 Financial Results 8/14/2014 8:21:03 AM
InSite Vision (ISV) To Report Second Quarter 2014 Financial Results On August 13, 2014 8/5/2014 10:08:38 AM
InSite Vision (ISV) To Webcast Annual Meeting Of Stockholders On July 16, 2014 7/16/2014 11:24:32 AM
InSite Vision (ISV) Announces The Issuance Of Broad U.S. Patent Covering Bromfenac Formulations In Durasite® 7/16/2014 8:10:35 AM
InSite Vision (ISV) Plans To Submit New Drug Application To FDA For Dexasiteâ„¢ For The Treatment Of Blepharitis In Adults 7/8/2014 6:36:24 AM
InSite Vision (ISV) Announces Agreement With Noteholders To Extinguish Debt In Exchange For One-Time Payment 6/12/2014 9:25:48 AM
InSite Vision (ISV) And Senju Pharmaceutical Co., Ltd. Announce Collaboration To Develop And Commercialize Azithromycin Ophthalmic Solution Using Durasite® In Japan 6/10/2014 10:03:16 AM
InSite Vision (ISV) Receives Notice Of Allowance From USPTO Covering Bromfenac Formulations In DuraSite® 6/4/2014 8:29:04 AM